Stanker James H has filed 11 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 1675 shares of Processa Pharmaceuticals, Inc. ($PCSA) on April 05, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | M | Common Stock | 1675 | $0.00 | 6,638.0000 | 0 | 33.75% | 0.00% |
| April 5, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | F | Common Stock | 518 | $2.79 | 6,120.0000 | 0 | 7.80% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | M | Common Stock | 644 | $0.00 | 6,764.0000 | 0 | 10.52% | 0.00% |
| July 10, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | F | Common Stock | 282 | $1.71 | 6,482.0000 | 0 | 4.17% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | A | Restricted Stock Units | 3077 | $0.00 | 26,470.0000 | 0 | 13.15% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | A | Restricted Stock Units | 2307 | $0.00 | 28,777.0000 | 0 | 8.72% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | A | Restricted Stock Units | 385 | $0.00 | 29,162.0000 | 0 | 1.34% | 0.00% |
| June 28, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | A | Restricted Stock Units | 385 | $0.00 | 29,547.0000 | 0 | 1.32% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | M | Common Stock | 1675 | $0.00 | 6,638.0000 | 0 | 33.75% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | F | Common Stock | 518 | $2.79 | 6,120.0000 | 0 | 7.80% | 0.00% |
| Jan. 1, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Stanker James H | Chief Financial Officer | M | Restricted Stock Units | 1675 | $0.00 | 24,037.0000 | 0 | 6.51% | 0.00% |